The learning objectives are:

n  Recognize the similarities between non-infectious granulomatous disease in primary autoimmune versus primary immunodeficiency disorders (PIDD)

n  Understand the indications for biologics in granulomatous disorders

n  Compare and contrast the risks and benefits of biologics in granulomatous disease